Michael Ominsky
AeroLeads people directory · profile

Michael Ominsky Email & Phone Number

Head of Skeletal Science, Clinical Development at Ascendis Pharma at Ascendis Pharma
Location: Ann Arbor, Michigan, United States 10 work roles 4 schools
1 work email found @ultragenyx.com LinkedIn matched
✓ Verified May 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email m****@ultragenyx.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Ascendis Pharma
Role
Head of Skeletal Science, Clinical Development at Ascendis Pharma
Location
Ann Arbor, Michigan, United States
Company size
417 employees

Who is Michael Ominsky? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Michael Ominsky is listed as Head of Skeletal Science, Clinical Development at Ascendis Pharma at Ascendis Pharma, a company with 417 employees, based in Ann Arbor, Michigan, United States. AeroLeads shows a work email signal at ultragenyx.com and a matched LinkedIn profile for Michael Ominsky.

Michael Ominsky previously worked as Head of Skeletal Science, Clinical Development at Ascendis Pharma and Director, Clinical Development at Ultragenyx Pharmaceutical Inc.. Michael Ominsky holds Doctor Of Philosophy (Ph.D.), Biomedical Engineering from University Of Michigan.

Company email context

Email format at Ascendis Pharma

This section adds company-level context without repeating Michael Ominsky's masked contact details.

{first_initial}{last}@ultragenyx.com
86% confidence

AeroLeads found 1 current-domain work email signal for Michael Ominsky. Compare company email patterns before reaching out.

View email format View company profile Management contacts
Profile bio

About Michael Ominsky

Experienced industry scientist with expertise in the fields of osteoporosis, orthopaedics, and rare disease. Currently working as Head of Skeletal Science in Clinical Development at Ascendis, supporting their Endocrine rare disease portfolio. Previously worked for 2 years in Clinical Development at Ultragenyx, leading the initiation of the setrusumab clinical program in osteogenesis imperfecta. Prior 4 years at Radius Health as a Director, Scientific Affairs and Medical Science Liaison, collaborating with Medical Affairs, Research, and Clinical Development to provide strategic support for their Bone/Endocrine portfolio. During the previous 12+ years at Amgen, directed pharmacology efforts to evaluate for bone therapeutics in animal models. Worked closely and cross-functionally to support the development of bone therapeutics of which two became marketed drugs for osteoporosis. Presented at numerous international scientific meetings and published 75+ peer-reviewed journal articles, generally focused on the effects of PTH1R agonists and therapeutic antibodies to RANKL, sclerostin, and DKK1. https://www.researchgate.net/profile/Michael_Ominsky

Listed skills include Clinical Development, Biotechnology, Life Sciences, Animal Models, and 11 others.

Current workplace

Michael Ominsky's current company

Company context helps verify the profile and gives searchers a useful next step.

Ascendis Pharma
Ascendis Pharma
Head of Skeletal Science, Clinical Development at Ascendis Pharma
denmark, western australia, australia
Website
ascendispharma.com
Employees
417
AeroLeads page
Company profile
View company profile Email format
10 roles

Michael Ominsky work experience

A career timeline built from the work history available for this profile.

Head Of Skeletal Science, Clinical Development

Current
Ascendis Pharma
Nov 2022 - Present

Scientific Director

Amgen
Jul 2012 - Jul 2016

Principal Scientist

Amgen
Mar 2009 - Jan 2012

Senior Scientist

Amgen

ASBMR Young Investigator Award (2006)

Mar 2006 - Mar 2009

Scientist

Amgen
Mar 2004 - Mar 2006

Post-Doctoral Fellow

University Of Michigan

Orthopaedic Research Laboratories - Director: Steven A. Goldstein

May 2003 - Mar 2004

Graduate Research Assistant

University Of Michigan

Orthopaedic Research Laboratories - Director: Steven A. GoldsteinProjects included: Finite element modeling to estimate trabecular bone strength, biomechanical comparison of lumbo-sacral fixation techniques, development of rabbit and porcine models of scoliosis progression in juvenile animals

Sep 1995 - Apr 2003
Team & coworkers

Colleagues at Ascendis Pharma

Other employees you can reach at ascendispharma.com. View company contacts for 417 employees →

MD Mike Dewitt Mike Dewitt Colleague at Ascendis Pharma Laurel, Mississippi, United States, United States View → TC Thomas Carlo Maria Topini Thomas Carlo Maria Topini Colleague at Ascendis Pharma Parma, Emilia-Romagna, Italy, Italy View → NP Nis Pedersen Nis Pedersen Colleague at Ascendis Pharma Copenhagen, Capital Region Of Denmark, Denmark, Denmark View → FP Florian P. Florian P. Colleague at Ascendis Pharma Heidelberg, Baden-Württemberg, Germany, Germany View → CL Clara Løvstrup Germansen Clara Løvstrup Germansen Colleague at Ascendis Pharma Copenhagen, Capital Region Of Denmark, Denmark, Denmark View → MS Mie Sandholdt Jensen Mie Sandholdt Jensen Colleague at Ascendis Pharma Copenhagen, Capital Region Of Denmark, Denmark, Denmark View → CL Casper Lykke Hansen Casper Lykke Hansen Colleague at Ascendis Pharma Copenhagen, Capital Region Of Denmark, Denmark, Denmark View → AA Annemette Asker Boye Annemette Asker Boye Colleague at Ascendis Pharma Denmark, Denmark View → CA Charlotte Albæk Thrue Charlotte Albæk Thrue Colleague at Ascendis Pharma Copenhagen Metropolitan Area, Denmark View → BR Baru Ren Baru Ren Colleague at Ascendis Pharma Værløse, Capital Region Of Denmark, Denmark, Denmark View →
4 education records

Michael Ominsky education

Doctor Of Philosophy (Ph.D.), Biomedical Engineering

University Of Michigan

Center for Organogenesis Fellowship (2000-2001) Ph.D Thesis: Effects of hydrostatic pressure, biaxial strain, and fluid shear on.

Master Of Science (M.S.), Mechanical Engineering

University Of Michigan

Master Of Science (M.S.), Bioengineering And Biomedical Engineering

University Of Michigan

GAANN Fellowship (1995-1997)

Bachelor Of Science (B.S.), Bioengineering And Biomedical Engineering

Duke University

Activities and Societies: Alpha Phi OmegaGraduated Magna Cum Laude, Received National Merit Scholarship (1995) and IBM Thomas J. Watson.

FAQ

Frequently asked questions about Michael Ominsky

Quick answers generated from the profile data available on this page.

What company does Michael Ominsky work for?

Michael Ominsky works for Ascendis Pharma.

What is Michael Ominsky's role at Ascendis Pharma?

Michael Ominsky is listed as Head of Skeletal Science, Clinical Development at Ascendis Pharma at Ascendis Pharma.

What is Michael Ominsky's email address?

AeroLeads has found 1 work email signal at @ultragenyx.com for Michael Ominsky at Ascendis Pharma.

Where is Michael Ominsky based?

Michael Ominsky is based in Ann Arbor, Michigan, United States while working with Ascendis Pharma.

What companies has Michael Ominsky worked for?

Michael Ominsky has worked for Ascendis Pharma, Ultragenyx Pharmaceutical Inc., Radius Health, Inc., Amgen, and University Of Michigan.

Who are Michael Ominsky's colleagues at Ascendis Pharma?

Michael Ominsky's colleagues at Ascendis Pharma include Mike Dewitt, Thomas Carlo Maria Topini, Nis Pedersen, Florian P., and Clara Løvstrup Germansen.

How can I contact Michael Ominsky?

You can use AeroLeads to view verified contact signals for Michael Ominsky at Ascendis Pharma, including work email, phone, and LinkedIn data when available.

What schools did Michael Ominsky attend?

Michael Ominsky holds Doctor Of Philosophy (Ph.D.), Biomedical Engineering from University Of Michigan.

What skills is Michael Ominsky known for?

Michael Ominsky is listed with skills including Clinical Development, Biotechnology, Life Sciences, Animal Models, Biomedical Engineering, Molecular Biology, Pharmaceutical Industry, and Cell.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.